Annals of Medical and Surgical Dermatology

ABSTRACT

Over the last decade, superficial fungal infection (tinea corporis, tinea cruris, and tinea faciei) has been challenged by a rise in the incidence of Trichophyton mentagrophytes species, poor or variable response to antifungal therapy (clinical cure, no response, and/or aggravation of symptoms after the initiation of an effective drug), frequent recurrence despite prolonged antifungal therapy, recurrence of lesion with diverse morphology, and/or lack of correlation between drug resistance and treatment outcome; poor correlation of risk factor (fungal infection of nail and disease in families) to chronic fungal disease, and recurrence was confined to treated tinea sites [1-8].

KEYWORDS